TY  - GEN
AU  - Sgarra,Luca
AU  - Addabbo,Francesco
AU  - Potenza,Maria Assunta
AU  - Montagnani,Monica
TI  - Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiology
SN  - 1522-1555
PY  - 2012///0717
KW  - Coronary Artery Disease
KW  - drug therapy
KW  - Diabetes Mellitus, Type 2
KW  - Disease Progression
KW  - Endothelium, Vascular
KW  - drug effects
KW  - Humans
KW  - Hypoglycemic Agents
KW  - adverse effects
KW  - Risk Assessment
KW  - Risk Factors
KW  - Rosiglitazone
KW  - Thiazolidinediones
KW  - administration & dosage
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1152/ajpendo.00038.2012
ER  -